Cargando…

Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain

[Image: see text] The P300/CBP-associated factor plays a central role in retroviral infection and cancer development, and the C-terminal bromodomain provides an opportunity for selective targeting. Here, we report several new classes of acetyl-lysine mimetic ligands ranging from mM to low micromolar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaikuad, Apirat, Lang, Steffen, Brennan, Paul E., Temperini, Claudia, Fedorov, Oleg, Hollander, Johan, Nachane, Ruta, Abell, Chris, Müller, Susanne, Siegal, Gregg, Knapp, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2016
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770306/ https://www.ncbi.nlm.nih.gov/pubmed/26731131 http://dx.doi.org/10.1021/acs.jmedchem.5b01719

Ejemplares similares

Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
por: Ferguson, Fleur M., et al.
Publicado: (2013)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
por: Hay, Duncan A., et al.
Publicado: (2014)

CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation
por: Olzscha, Heidi, et al.
Publicado: (2017)

Increasing Chemical Space Coverage by Combining Empirical and Computational Fragment Screens
por: Barelier, Sarah, et al.
Publicado: (2014)

CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs
por: Strachowska, Magdalena, et al.
Publicado: (2021)

Discovery of a PCAF Bromodomain Chemical Probe
por: Moustakim, Moses, et al.
Publicado: (2016)

Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer
por: Hogg, Simon J., et al.
Publicado: (2022)

Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B
por: Drouin, Ludovic, et al.
Publicado: (2015)

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022)

Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B
por: Chen, Peiling, et al.
Publicado: (2015)

Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015)

Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1
por: Ni, Xiaomin, et al.
Publicado: (2020)

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
por: Zhang, Xin, et al.
Publicado: (2020)

Curcumin, COX-2, and Protein p300/CBP
por: Jung, Ki Tae, et al.
Publicado: (2014)

Dimeric structure of p300/CBP associated factor
por: Shi, Shasha, et al.
Publicado: (2014)

Correction to Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2016)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
por: Filippakopoulos, Panagis, et al.
Publicado: (2012)

Defined PEG smears as an alternative approach to enhance the search for crystallization conditions and crystal-quality improvement in reduced screens
por: Chaikuad, Apirat, et al.
Publicado: (2015)

Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening
por: Zhang, Feng-cai, et al.
Publicado: (2019)

Genomic occupancy of the transcriptional co-activators p300 and CBP
por: Holmqvist, Per-Henrik, et al.
Publicado: (2013)

Epigenetic mechanisms to propagate histone acetylation by p300/CBP
por: Kikuchi, Masaki, et al.
Publicado: (2023)

A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
por: Cox, Oakley B., et al.
Publicado: (2016)

Comparative structural analyses of the NHL domains from the human E3 ligase TRIM–NHL family
por: Chaikuad, Apirat, et al.
Publicado: (2022)

Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
por: Bennett, James, et al.
Publicado: (2015)

Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation
por: Meier, Julia C., et al.
Publicado: (2017)

Structural insights into a regulatory mechanism of FIR RRM1–FUSE interaction
por: Ni, Xiaomin, et al.
Publicado: (2023)

Is histone acetylation the most important physiological function for CBP and p300?
por: Bedford, David C., et al.
Publicado: (2012)

HBZ inhibits the HAT activity of the cellular coactivators p300 and CBP
por: Wright, Diana, et al.
Publicado: (2011)

The prognostic capacities of CBP and p300 in locally advanced rectal cancer
por: Rühlmann, Felix, et al.
Publicado: (2019)

A chemical toolbox for the study of bromodomains and epigenetic signaling
por: Wu, Qin, et al.
Publicado: (2019)

Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
por: Hewings, David S., et al.
Publicado: (2013)

Structural Comparison of Human Mammalian Ste20-Like Kinases
por: Record, Christopher J., et al.
Publicado: (2010)

Fragment-Based Screening of the Bromodomain of ATAD2
por: Harner, Mary J., et al.
Publicado: (2014)

Bromodomains as therapeutic targets
por: Muller, Susanne, et al.
Publicado: (2011)

3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
por: Hewings, David S., et al.
Publicado: (2011)

[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains
por: Fedorov, Oleg, et al.
Publicado: (2013)

Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts
por: Chen, Guozhen, et al.
Publicado: (2009)

CBP / p300-mediated acetylation of histone H3 on lysine 56
por: Das, Chandrima, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_p58u3sjjclqj7rf285920dgpji